Fibrinski lepak (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fibrinski lepak" in Serbian language version.

refsWebsite

Global rank Serbian rank

9doi.org

2^nd place

4^th place

7nih.gov

4^th place

8^th place

3tga.gov.au

3,984^th place

low place

3medicines.org.uk

3,823^rd place

low place

2archive.org

6^th place

5^th place

1canada.ca

1,712^th place

6,766^th place

1web.archive.org

1^st place

1harvard.edu

18^th place

28^th place

1fda.gov

447^th place

925^th place

archive.org

Gibble, J. W.; Ness, P. M. (1990). „Fibrin glue: The perfect operative sealant?”. Transfusion. 30 (8): 741—7. PMID 2219264. doi:10.1046/j.1537-2995.1990.30891020337.x. .
Buchta C, Hedrich HC, Macher M, Höcker P, Redl H (2005). „Biochemical characterization of autologous fibrin sealants produced by CryoSeal and Vivostat in comparison to the homologous fibrin sealant product Tissucol/Tisseel”. Biomaterials. 26 (31): 6233—41. doi:10.1016/j.biomaterials.2005.04.014. .

canada.ca

„Health product highlights 2021: Annexes of products approved in 2021”. Health Canada. 3. 8. 2022. Приступљено 25. 3. 2024.

doi.org

Albala MD (2003). „Fibrin sealants in clinical practice”. Cardiovasc Surg. 11 (1): 5—11. PMID 12869982. doi:10.1016/S0967-2109(03)00065-6. .
Jackson, M. R. (2001). „Fibrin sealants in surgical practice: an overview”. Am J Surg. 182 (2): 1S—7S. PMID 11566470. doi:10.1016/S0002-9610(01)00770-X. .
Spotnitz WD (2014). „Fibrin sealant: The only approved hemostat, sealant, and adhesive – a laboratory and clinical perspective”. ISRN Surg. 2014: 203943. PMC 3960746 . PMID 24729902. doi:10.1155/2014/203943 . .
Gibble, J. W.; Ness, P. M. (1990). „Fibrin glue: The perfect operative sealant?”. Transfusion. 30 (8): 741—7. PMID 2219264. doi:10.1046/j.1537-2995.1990.30891020337.x. .
Bergel, Salo (1909). „Über Wirkungen des Fibrins”. Dtsch Med WSCHR. 35 (15): 663—5. doi:10.1055/s-0029-1201395. .
Clark, R. A. (2001). „Fibrin and wound healing”. Ann N Y Acad Sci. 936 (1): 355—67. Bibcode:2001NYASA.936..355C. PMID 11460492. doi:10.1111/j.1749-6632.2001.tb03522.x. .
Laurens N, Koolwijk P, de Maat MP (2006). „J Fibrin structure and wound healing”. Thromb Haemost. 4 (5): 932—9. PMID 16689737. doi:10.1111/j.1538-7836.2006.01861.x.
Wozniak, G. (2003). „Fibrin sealants in supporting surgical techniques: the importance of individual components”. Cardiovasc Surg. 11 (1): 17—21. PMID 12869984. doi:10.1016/S0967-2109(03)00067-X. .
Buchta C, Hedrich HC, Macher M, Höcker P, Redl H (2005). „Biochemical characterization of autologous fibrin sealants produced by CryoSeal and Vivostat in comparison to the homologous fibrin sealant product Tissucol/Tisseel”. Biomaterials. 26 (31): 6233—41. doi:10.1016/j.biomaterials.2005.04.014. .

fda.gov

„Evicel Fibrin Sealant (Human)”. U.S. Food and Drug Administration (FDA). 22. 7. 2017.

harvard.edu

adsabs.harvard.edu

Clark, R. A. (2001). „Fibrin and wound healing”. Ann N Y Acad Sci. 936 (1): 355—67. Bibcode:2001NYASA.936..355C. PMID 11460492. doi:10.1111/j.1749-6632.2001.tb03522.x. .

medicines.org.uk

„TachoSil sealant matrix - Summary of Product Characteristics (SmPC)”. (emc). 31. 1. 2020. Архивирано из оригинала 10. 7. 2020. г. Приступљено 10. 7. 2020.
„Tisseel Ready to use Solutions for Sealant - Summary of Product Characteristics (SmPC)”. (emc). 30. 12. 2019. Приступљено 10. 7. 2020.
„Artiss Solutions for Sealant - Summary of Product Characteristics (SmPC)”. (emc). 29. 1. 2019. Приступљено 10. 7. 2020.

nih.gov

ncbi.nlm.nih.gov

Albala MD (2003). „Fibrin sealants in clinical practice”. Cardiovasc Surg. 11 (1): 5—11. PMID 12869982. doi:10.1016/S0967-2109(03)00065-6. .
Jackson, M. R. (2001). „Fibrin sealants in surgical practice: an overview”. Am J Surg. 182 (2): 1S—7S. PMID 11566470. doi:10.1016/S0002-9610(01)00770-X. .
Spotnitz WD (2014). „Fibrin sealant: The only approved hemostat, sealant, and adhesive – a laboratory and clinical perspective”. ISRN Surg. 2014: 203943. PMC 3960746 . PMID 24729902. doi:10.1155/2014/203943 . .
Gibble, J. W.; Ness, P. M. (1990). „Fibrin glue: The perfect operative sealant?”. Transfusion. 30 (8): 741—7. PMID 2219264. doi:10.1046/j.1537-2995.1990.30891020337.x. .
Clark, R. A. (2001). „Fibrin and wound healing”. Ann N Y Acad Sci. 936 (1): 355—67. Bibcode:2001NYASA.936..355C. PMID 11460492. doi:10.1111/j.1749-6632.2001.tb03522.x. .
Laurens N, Koolwijk P, de Maat MP (2006). „J Fibrin structure and wound healing”. Thromb Haemost. 4 (5): 932—9. PMID 16689737. doi:10.1111/j.1538-7836.2006.01861.x.
Wozniak, G. (2003). „Fibrin sealants in supporting surgical techniques: the importance of individual components”. Cardiovasc Surg. 11 (1): 17—21. PMID 12869984. doi:10.1016/S0967-2109(03)00067-X. .

tga.gov.au

„VeraSeal”. Therapeutic Goods Administration (TGA). 12. 11. 2021. Приступљено 28. 12. 2021.
„Updates to the Prescribing Medicines in Pregnancy database”. Therapeutic Goods Administration (TGA). 12. 5. 2022. Приступљено 13. 5. 2022.
„AusPAR: Human Fibrinogen / Human Thrombin”. Therapeutic Goods Administration (TGA). 29. 6. 2022. Приступљено 17. 7. 2022.

web.archive.org

„TachoSil sealant matrix - Summary of Product Characteristics (SmPC)”. (emc). 31. 1. 2020. Архивирано из оригинала 10. 7. 2020. г. Приступљено 10. 7. 2020.